Electra Therapeutics, Inc. is a clinical stage biotechnology company. It is engaged in therapies against novel targets for diseases in immunology and cancer. The company was founded by Adam Rosenthal on October 11, 2018 and is headquartered in South San Francisco, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Electra Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Electra Therapeutics Inc market cap is $650.89M.
What is the 52-week high for Electra Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Electra Therapeutics Inc 52 week high is $15.50 as of October 05, 2026.
What is the 52-week low for Electra Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Electra Therapeutics Inc 52 week low is $9.88 as of October 05, 2026.
What is Electra Therapeutics Inc stock price today?
Electra Therapeutics Inc stock price today is $10.37.
What was Electra Therapeutics Inc stock price yesterday?
Electra Therapeutics Inc stock price yesterday was $10.68.
What is the 50-day moving average of Electra Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Electra Therapeutics Inc 50-day moving average is $12.23.